Plasma Trimethylamine N ‐Oxide Levels in Nondialysis Chronic Kidney Disease Patients Following Meal Challenge
Molecular Nutrition & Food Research · 2025
DOI: 10.1002/mnfr.70121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2025. Verfasst von Bruna Regis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Methylamines, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico-(CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) support Denise Mafra research.
Abstract (Originalsprache)
Trimethylamine N ‐oxide (TMAO) is a uremic toxin accumulated in patients with chronic kidney disease (CKD) and involved with atherosclerosis. TMAO is derived from the gut microbiota (nutrient fermentation) and is found in some fish and seafood. This pilot study evaluated the acute effects of cod fish, red meat, and vegetable meal consumption on plasma TMAO levels in nondialysis CKD patients. Patients (five women, three men, 72.5 [7.7] years, body mass index [BMI], 25.6 [1.4] kg/m 2 , glomerular filtration rate, 32.5 [18.5] mL/min) consumed lunches containing codfish, red meat, and chickpeas, within a 7‐day interval between meals. TMAO plasma levels were assessed using the HPLC‐EM/EM method before and after the 4‐h meal challenge. Patients presented TMAO plasma levels of 9.06 µM. Consumption of codfish significantly increases the TMAO levels (to 23.5 µM, p < 0.001) compared to red meat and chickpeas. We conclude that codfish, compared to red meat and vegetable meal, provoked a transient elevation in TMAO levels in patients with CKD. Therefore, this result suggests that it is prudent to prescribe fish with low TMAO content for these patients. The response to ingesting TMAO‐rich foods in CKD patients needs more study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, Rio de Janeiro, Brazil.
- Nutrition Faculty, Fluminense Federal University (UFF), Niterói, Rio de Janeiro, Brazil.
- Graduate Program in Food, Nutrition and Health - Institute of Nutrition, State University of Rio de Janeiro (UERJ), Rio de Janeiro, Rio de Janeiro, Brazil.
- HIV/AIDS Clinical Research Center, National Institute of Infectology Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Rio de Janeiro, Brazil.
- Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Bruna Regis, Natalia A Borges, Denise Mafra
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico-(CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) support Denise Mafra research
Zitieren
APA
Regis, B., Passeri, L., Moreira, N. X., Borges, N. A., Ribeiro-Alves, M., & Mafra, D. (2025). Plasma Trimethylamine N ‐Oxide Levels in Nondialysis Chronic Kidney Disease Patients Following Meal Challenge. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70121
Vancouver
Regis B, Passeri L, Moreira NX, Borges NA, Ribeiro-Alves M, Mafra D. Plasma Trimethylamine N ‐Oxide Levels in Nondialysis Chronic Kidney Disease Patients Following Meal Challenge. Molecular Nutrition & Food Research. 2025. doi:10.1002/mnfr.70121
BibTeX
@article{Regis2025,
author = {Regis, Bruna and Passeri, Luna and Moreira, Nara X and Borges, Natalia A and Ribeiro-Alves, Marcelo and Mafra, Denise},
title = {Plasma Trimethylamine N ‐Oxide Levels in Nondialysis Chronic Kidney Disease Patients Following Meal Challenge},
journal = {Molecular Nutrition & Food Research},
year = {2025},
doi = {10.1002/mnfr.70121}
}
EUVIMED